doi:

DOI: 10.3724/SP.J.1008.2015.01314

Academic Journal of Second Military Medical University (第二军医大学学报) 2015/36:12 PP.1314-1318

miR-141 inhibits the proliferation of head and neck squamous cell carcinoma


Abstract:
Objective To study the effect of miR-141 on the proliferation of head and neck squamous cell carcinoma(HNSCC)cells. Methods The expressions of miR-141 in 19 HNSCC tissues and the matched adjacent normal tissues were analyzed by qRT-PCR. The miR-141 in Hep-2 or SCC-9 cells was overexpressed or down-regulated by miR-141 mimics or miR-141 ASO transfection. Then the effects of overexpression or down-regulation of miR-141 on cellular proliferation were analyzed by MTT experiment. The targeted genes of miR-141 were predicted by bioinformatics algorithms. Results The expression of miR-141 in HNSCC tissues was found significantly lower than that in matched normal tissue(P<0.05). Overexpression of miR-141 significantly inhibited the proliferation of Hep-2 and SCC-9 cells, and down-regulation of miR-141 significantly promoted the proliferation of Hep-2 and SCC-9 cells(P<0.05). Bioinformatics algorithms showed that ZEB1 was likely to be a targeted gene of miR-141 in HNSCC. Conclusion miR-141 may inhibit HNSCC cell proliferation via ZEB1.

Key words:microRNA-141;head and neck neoplasms;squamous cell carcinoma;ZEB1;cell proliferation

ReleaseDate:2016-05-27 09:20:00



[1] Pignon J P, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer[J]. Lancet, 2000, 355: 949-955.

[2] Suh Y, Amelio I, Guerrero Urbano T, Tavassoli M. Clinical update on cancer: molecular oncology of head and neck cancer[J]. Cell Death Dis, 2014, 5: e1018.

[3] Kim V N, Han J, Siomi M C. Biogenesis of small RNAs in animals [J]. Nat Rev Mol Cell Biol, 2009, 10: 126-139.

[4] Bartel D P. MicroRNAs: target recognition and regulatory functions [J]. Cell, 2009, 136: 215-233.

[5] Valencia-Sanchez M A, Liu J, Hannon G J, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs[J]. Genes Dev, 2006, 20: 515-524.

[6] Iorio M V, Croce C M. MicroRNAs in cancer: small molecules with a huge impact [J]. J Clin Oncol, 2009, 27: 5848-5856.

[7] Yan B, Fu Q, Lai L, Tao X, Fei Y, Shen J, et al. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells [J]. Mol Med Rep, 2012, 6: 675-681.

[8] Harris T, Jimenez L, Kawachi N, Fan J B, Chen J, Belbin T, et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas [J]. Am J Pathol, 2012, 180: 917-928.

[9] Kinoshita T, Nohata N, Fuse M, Hanazawa T, Kikkawa N, Fujimura L, et al. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma [J]. Biochem Biophys Res Commun, 2012, 418: 378-383.

[10] Zhu Z M, Xu Y F, Su Q J, Du J D, Tan X L, Tu Y L, et al. Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma [J]. Mol Cell Biochem, 2014, 388: 39-49.

[11] Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy, Mariani O, et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response [J]. Nat Med, 2011, 17: 1627-1635.

[12] Zhou X, Xia Y, Su J, Zhang G. Down-regulation of miR-141 induced by Helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4[J]. Cell Physiol Biochem, 2014, 33:1003-1012.

[13] Wu N, Liu C, Bai C, Han Y P, Cho W C, Li Q. Over-expression of deubiquitinating enzyme USP 14 in lung adenocarcinoma promotes proliferation through the accumulation of β-catenin [J]. Int J Mol Sci, 2013, 14: 10749-10760.

[14] Wu N, Zhang C, Bai C, Han Y P, Cho W C, Li Q. MiR-4782-3p inhibited non-small cell lung cancer growth via USP14[J]. Cell Physiol Biochem, 2014, 33: 457-467.

[15] Song B, Zhang C, Li G, Jin G, Liu C. MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88[J]. Cell Physiol Biochem, 2015, 35: 1167-1177.

[16] Zhao G, Wang B, Liu Y, Zhang J G, Deng S C, Qin Q, et al. MiRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4 [J]. Mol Cancer Ther, 2013, 12: 2569-2580.

[17] Gao Y C, Wu J. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer [J]. Tumour Biol, 2015, 36: 4843-4850.

[18] Zuo Q F, Zhang R, Li B S, Zhao Y L, Zhuang Y, Yu T, et al. MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ[J]. Cell Death Dis, 2015, 6: e1623.

[19] Wellner U, Schubert J, Burk U C, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs [J]. Nat Cell Biol, 2009, 11: 1487-1495.

[20] Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina H G, et al. TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RⅢ and p38α/β signalling [J]. Nat Cell Biol, 2013, 15: 1351-1361.

[21] Koyama-Nasu R, Nasu-Nishimura Y, Todo T, Ino Y, Saito N, Aburatani H, et al. The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells [J]. Oncogene, 2013, 32: 3840-3845.